NCT04887870: An ongoing trial by Mirati Therapeutics Inc.
This trial is ongoing. It must report results 2 weeks, 3 days from now.
Full data
| Full entry on ClinicalTrials.gov | NCT04887870 |
|---|---|
| Title | A Multicenter, Open-label Rollover Study of Sitravatinib Alone or in Combination With Other Anticancer Therapies in Patients With Advanced or Metastatic Solid Malignancies |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | June 29, 2021 |
| Completion date | April 21, 2025 |
| Required reporting date | April 21, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | March 26, 2026 |
| Days late | None |